Agritek Holdings, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AGTK research report →
Companywww.agritekholdings.com
Agritek Holdings, Inc. distributes hemp and cannabis products under the Hemp Pops, MD Vapes, Rehab Rx, Higher Society, and California Premiums brands in the United States. Its products include human ingestible, such as tinctures, capsules, and gummies; CBD edibles; topicals; and pet products.
- CEO
- Howard Cass
- IPO
- 1998
- Employees
- 2
- HQ
- Miami, FL, US
Price Chart
Valuation
- Market Cap
- $5.44K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.40
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 204.41%
- ROIC
- 212.92%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-8,046,000 · -469.83%
- EPS
- $-0.57 · -67.65%
- Op Income
- $-5,828,000
- FCF YoY
- -14.50%
Performance & Tape
- 52W High
- $0.50
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -8.72
- Avg Volume
- 2.98K
Get TickerSpark's AI analysis on AGTK
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 3, 17 | FRIEDMAN BARRY MICHAEL | sell | 504,174 |
| Mar 7, 17 | FRIEDMAN BARRY MICHAEL | sell | 302,000 |
| Mar 16, 17 | FRIEDMAN BARRY MICHAEL | sell | 500,000 |
| Jan 30, 17 | FRIEDMAN BARRY MICHAEL | other | 10,000,000 |
| Feb 15, 17 | FRIEDMAN BARRY MICHAEL | sell | 743,826 |
| Feb 22, 17 | FRIEDMAN BARRY MICHAEL | sell | 200,000 |
| Dec 31, 16 | FRIEDMAN BARRY MICHAEL | other | 0 |
| Jan 27, 17 | FRIEDMAN BARRY MICHAEL | other | 626,000 |
| Jan 18, 17 | FRIEDMAN BARRY MICHAEL | other | 650,000 |
| Mar 20, 15 | BRAUNE JUSTIN | other | 15,000,000 |
Our AGTK Coverage
We haven't published any research on AGTK yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AGTK Report →